Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)

Clinical trial NCT07473804 · RECRUITING

Trial details

NCT number: NCT07473804
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status: RECRUITING
Study type: OBSERVATIONAL

Neonatal Salt Loss Congenital Adrenal Hyperplasia (CAH)

Start date: 2025-04-14
Primary completion: 2026-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.